Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | CTSK | P43235 | 4/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | ADH1B | P00325 | 2/20 | 0.35 |
| ▸ | ADH1C | P00326 | 2/20 | 0.35 |
| ▸ | ADH1A | P07327 | 2/20 | 0.35 |
| ▸ | ADH7 | P40394 | 2/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.34 |
| ▸ | GAPDH | P04406 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL348615 | 0.95 | TSHR (0.80) | TSHRSMN1; SMN2CTSKDNM1ALDH1A1 | |
| SCHEMBL547296 | 0.92 | TSHR (0.62) | TSHRSMN1; SMN2FDPSADH1BADH1C | |
| SCHEMBL29291465 | 0.90 | TSHR (0.60) | TSHRSMN1; SMN2DNM1FDPSADH1B | |
| SCHEMBL28625479 | 0.90 | TSHR (0.60) | TSHRSMN1; SMN2DNM1FDPSADH1B | |
| SCHEMBL28625631 | 0.90 | TSHR (0.60) | TSHRSMN1; SMN2DNM1FDPSADH1B | |
| SCHEMBL9320445 | 0.90 | TSHR (0.60) | TSHRSMN1; SMN2DNM1FDPSADH1B | |
| SCHEMBL6925908 | 0.90 | TSHR (0.60) | TSHRSMN1; SMN2DNM1FDPSADH1B | |
| SCHEMBL29291468 | 0.90 | TSHR (0.60) | TSHRSMN1; SMN2DNM1FDPSADH1B | |
| SCHEMBL277792 | 0.90 | TSHR (0.60) | TSHRSMN1; SMN2DNM1FDPSADH1B | |
| SCHEMBL2925442 | 0.90 | TSHR (0.60) | TSHRSMN1; SMN2DNM1FDPSADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4448171-B1 | TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-08-20 | — | — | EP | disclosed |
| EP-4448170-B1 | COMPOUNDS, TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-08-20 | — | — | EP | disclosed |
| US-20250128245-A1 | COMPOUNDS, TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-04-24 | — | — | US | disclosed |
| US-12246310-B2 | Processes for recovery of rhodium from a hydroformylation process | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-03-11 | — | — | US | disclosed |
| US-20250019334-A1 | HYDROFORMYLATION PROCESS FOR PREPARING LINEAR AND BRANCHED ALDEHYDES | NORTH CAROLINA STATE UNIVERSITY | 2025-01-16 | — | — | US | disclosed |
| EP-4054762-B1 | PROCESSES FOR RECOVERY OF RHODIUM FROM A HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-12-18 | — | — | EP | disclosed |
| US-20240399349-A1 | TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-12-05 | — | — | US | disclosed |
| EP-3710161-B1 | PROCESSES FOR RECOVERY OF RHODIUM FROM A HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-10-16 | — | — | EP | disclosed |
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-05-30 | — | — | US | disclosed |
| WO-2024107323-A1 | HETEROGENEOUS CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-05-23 | — | — | WO | disclosed |
| EP-0366561-A2 | 1-Azabicycloalkane derivatives, process for their preparation and their use as medicines | ROUSSEL-UCLAF (FR) | 1990-05-02 | — | — | EP | disclosed |
| US-4922028-A | Process for the hydroformylation of sulfur-containing thermally cracked petroleum residue and novel products thereof | EXXON RESEARCH & ENGINEERING COMPANY (US) | 1990-05-01 | — | — | US | disclosed |
| EP-0329670-A1 | A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF. | EXXON RESEARCH ENGINEERING CO (US) | 1989-08-30 | — | — | EP | disclosed |
| US-4861918-A | RHODIUM-TERITARY ORGANOPHOSPHINE COMPLEX | UNION CARBIDE CORPORATION (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0329670-A4 | A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF. | EXXON RESEARCH ENGINEERING CO (US) | 1989-08-16 | — | — | EP | disclosed |
| US-4757147-A | Imino-substituted piperidine compound | PETROLITE CORPORATION (US) | 1988-07-12 | — | — | US | disclosed |
| WO-1988002360-A1 | A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1988-04-07 | — | — | WO | disclosed |
| US-4625068-A | STERICALLY HINDERED PHOSPHINE LIGNANDS; CATALYSTS | EXXON CHEMICAL PATENTS INC. (US) | 1986-11-25 | — | — | US | disclosed |
| EP-0195656-A1 | Improved rhodium catalyzed hydroformylation of internal olefins | EXXON CHEMICAL PATENTS INC. (US) | 1986-09-24 | — | — | EP | disclosed |
| US-4020109-A | POLYMERIZATION AND ALDOL CONDENSATION INHIBITION | UNION OIL COMPANY OF CALIFORNIA (US) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250019334-A1 | HYDROFORMYLATION PROCESS FOR PREPARING LINEAR AND BRANCHED ALDEHYDES | CYP2F1, HOGA1, HAO2 | TSHR 3547/4885SMN1; SMN2 2394/4885CTSK 3653/4885 |
| US-20250128245-A1 | COMPOUNDS, TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | C1R, M6PR, FOLR1 | TSHR 359/4885SMN1; SMN2 2120/4885CTSK 2746/4885 |
| US-20240399349-A1 | TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | M6PR, KRAS, C1R | TSHR 3827/4885SMN1; SMN2 1997/4885CTSK 1908/4885 |
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | ADH1C, ADH5, ALDH2 | TSHR 4679/4885SMN1; SMN2 1192/4885CTSK 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.